Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Journal of Internal Medicine|March 7, 2022
Low-dose computed tomography lung cancer screening: Clinical evidence and implementation researchHarriet L Lancaster, Marjolein A Heuvelmans, Matthijs OudkerkEuropean Journal of Radiology|July 20, 2025
Comparison of nodule volumetric classification by using two different nodule segmentation algorithms in an LDCT lung cancer baseline screening datasetYifei Mao, Harriet L Lancaster, Marjolein A Heuvelmans, et al.European Journal of Cancer (Oxford, England : 1990)|March 1, 2025
Histological proven AI performance in the UKLS CT lung cancer screening study: Potential for workload reductionHarriet L Lancaster, Beibei Jiang, Michael P A Davies, et al.Scientific Reports|April 29, 2021
Seasonal prevalence and characteristics of low-dose CT detected lung nodules in a general Dutch populationHarriet L Lancaster, Marjolein A Heuvelmans, Gert Jan Pelgrim, et al.European Journal of Cancer (Oxford, England : 1990)|October 5, 2024
Lung cancer volume doubling time by computed tomography: A systematic review and meta-analysisBeibei Jiang, Daiwei Han, Carlijn M van der Aalst, et al.European Journal of Cancer (Oxford, England : 1990)|May 19, 2026
Incidence and lung cancer probability of new nodules in the UK lung screening trialBeibei Jiang, Harriet L Lancaster, Michael P A Davies, et al.European Journal of Cancer (Oxford, England : 1990)|November 30, 2025
AI performance for nodule volume doubling time in the follow-up of the UKLS lung cancer screening study compared to expert consensus and histological validationBeibei Jiang, Harriet L Lancaster, Michael P A Davies, et al.Lung Cancer (Amsterdam, Netherlands)|March 10, 2026
Volume and location of screen-detected lung nodules associated with lung cancer within two-year follow-up: Post hoc analysis from the UK Lung Cancer Screening (UKLS) trialOke Dimas Asmara, Harriet L Lancaster, John K Field, et al.European Journal of Cancer (Oxford, England : 1990)|January 4, 2025
Feasibility of AI as first reader in the 4-IN-THE-LUNG-RUN lung cancer screening trial: impact on negative-misclassifications and clinical referral rateAnna N H Walstra, Harriet L Lancaster, Marjolein A Heuvelmans, et al.European Radiology|March 24, 2026
Negligible impact of perifissural nodules in an AI-first reader workflow from UK lung screening trialBeibei Jiang, Daiwei Han, Jiali Cai, et al.Pageof 2